Share This Page
Drug Price Trends for HM NIGHT TIME LIQUID CAP
✉ Email this page to a colleague
Average Pharmacy Cost for HM NIGHT TIME LIQUID CAP
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| HM NIGHT TIME LIQUID CAP | 62011-0410-01 | 0.13222 | EACH | 2024-02-21 |
| HM NIGHT TIME LIQUID CAP | 62011-0410-01 | 0.12157 | EACH | 2024-01-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
HM NIGHT TIME LIQUID CAP Market Analysis and Financial Projection
Market Analysis and Price Projections for H & M Hennes & Mauritz AB (publ)
While the query mentions "HM NIGHT TIME LIQUID CAP," it appears there might be a confusion, as the provided sources and context pertain to H & M Hennes & Mauritz AB (publ), a retail clothing company, rather than a pharmaceutical product. Here’s a comprehensive analysis of H & M Hennes & Mauritz AB (publ) based on the available data.
Company Overview
H & M Hennes & Mauritz AB (publ) is a Swedish multinational clothing-retail company known for its fast-fashion business model. The company has a significant global presence and a long history of growth[4].
Market Capitalization and Financials
As of December 23, 2024, H & M Hennes & Mauritz AB has a market capitalization of approximately 239.07 billion SEK, which has decreased by 16.55% over the past year. The company's enterprise value stands at 288.73 billion SEK, with revenue of 234.94 billion SEK. The price-to-earnings ratio is 23.79[4].
Stock Performance and Trends
The stock has been in a rising trend in the short term. According to technical analysis, H & M Hennes & Mauritz AB (publ) is expected to rise by 15.20% over the next three months, with a 90% probability of the price ranging between kr209.63 and kr231.10 during this period. The stock holds buy signals from both short and long-term moving averages, indicating a positive forecast[2].
Short Interest and Analyst Ratings
As of December 15, 2024, the short interest in H & M Hennes & Mauritz AB (publ) dropped by 31.8% compared to November 30, 2024. The current short interest totals 4,500 shares, which is relatively low given the average daily volume of 114,800 shares. Analysts have mixed ratings, with one analyst rating the stock as a "sell," one as a "hold," two as a "buy," and one as a "strong buy." The overall average rating is "Moderate Buy"[1].
Technical Indicators and Support Levels
The stock has support levels at kr191.97 and kr183.68. A breakdown below these levels could issue sell signals. However, the current trend and accumulated volume suggest a buying opportunity, especially around the support level of kr185.60. The stock's daily movements are relatively controlled, with low volatility, making the risk considered very low[2].
Dividend and Earnings
H & M Hennes & Mauritz AB (publ) recently announced an increased dividend of $0.0625 per share, paid on November 29, 2024. The company reported earnings per share (EPS) of $0.03 for the quarter, slightly missing the consensus estimate of $0.04. The firm had revenue of $5.61 billion, which was below analysts' expectations of $5.84 billion[1].
Price Projections and Trading Expectations
For the upcoming trading days, the stock is expected to open at around kr193.82, with a possible trading interval of +/-kr4.27 (+/-2.19%) from the last closing price. The predicted opening price is based on the previous day's movements between high, low, and closing prices. The stock is anticipated to move within a range, supported by accumulated volume and technical indicators[2].
Risk and Stop-Loss
Given the low daily movements and good liquidity, the risk is considered very low. A recommended stop-loss level is around kr187.53, which is a 3.66% drop from the current price. This level helps in managing potential losses while allowing for the stock's expected rise[2].
Key Takeaways
- Market Capitalization: H & M Hennes & Mauritz AB has a market cap of 239.07 billion SEK.
- Stock Performance: Expected to rise by 15.20% over the next three months.
- Analyst Ratings: Average rating of "Moderate Buy."
- Technical Indicators: Buy signals from short and long-term moving averages.
- Dividend: Recently increased to $0.0625 per share.
- Risk Management: Low risk with recommended stop-loss at kr187.53.
FAQs
What is the current market capitalization of H & M Hennes & Mauritz AB (publ)?
The current market capitalization of H & M Hennes & Mauritz AB (publ) is approximately 239.07 billion SEK as of December 23, 2024[4].
What are the analyst ratings for H & M Hennes & Mauritz AB (publ)?
Analysts have rated the stock with one "sell," one "hold," two "buy," and one "strong buy" rating, resulting in an average rating of "Moderate Buy"[1].
What is the expected price movement for H & M Hennes & Mauritz AB (publ) in the next three months?
The stock is expected to rise by 15.20% over the next three months, with a 90% probability of the price ranging between kr209.63 and kr231.10[2].
What are the key support levels for H & M Hennes & Mauritz AB (publ)?
The key support levels are at kr191.97 and kr183.68, with an additional support level at kr185.60 from accumulated volume[2].
How has the short interest in H & M Hennes & Mauritz AB (publ) changed recently?
The short interest dropped by 31.8% from November 30, 2024, to December 15, 2024, totaling 4,500 shares[1].
What was the recent dividend announcement for H & M Hennes & Mauritz AB (publ)?
The company announced an increased dividend of $0.0625 per share, paid on November 29, 2024[1].
Cited Sources
- MarketBeat: "Short Interest in H & M Hennes & Mauritz AB (publ) Drops By 31.8%" - December 28, 2024.
- StockInvest.us: "H & M Hennes & Mauritz AB (publ) Stock Forecast" - Accessed December 2024.
- Vizient Inc.: "Vizient projects drug price inflation at 3.81%" - July 30, 2024. (Note: This source is unrelated to H & M Hennes & Mauritz AB but was included in the search results.)
- StockAnalysis.com: "H & M Hennes & Mauritz AB (STO: HM.B) Market Cap & Net Worth" - Accessed December 2024.
More… ↓
